{"2412.11671": {"publish_time": "2024-12-16", "title": "BioBridge: Unified Bio-Embedding with Bridging Modality in Code-Switched EMR", "paper_summary": "Pediatric Emergency Department (PED) overcrowding presents a significant\nglobal challenge, prompting the need for efficient solutions. This paper\nintroduces the BioBridge framework, a novel approach that applies Natural\nLanguage Processing (NLP) to Electronic Medical Records (EMRs) in written\nfree-text form to enhance decision-making in PED. In non-English speaking\ncountries, such as South Korea, EMR data is often written in a Code-Switching\n(CS) format that mixes the native language with English, with most\ncode-switched English words having clinical significance. The BioBridge\nframework consists of two core modules: \"bridging modality in context\" and\n\"unified bio-embedding.\" The \"bridging modality in context\" module improves the\ncontextual understanding of bilingual and code-switched EMRs. In the \"unified\nbio-embedding\" module, the knowledge of the model trained in the medical domain\nis injected into the encoder-based model to bridge the gap between the medical\nand general domains. Experimental results demonstrate that the proposed\nBioBridge significantly performance traditional machine learning and\npre-trained encoder-based models on several metrics, including F1 score, area\nunder the receiver operating characteristic curve (AUROC), area under the\nprecision-recall curve (AUPRC), and Brier score. Specifically, BioBridge-XLM\nachieved enhancements of 0.85% in F1 score, 0.75% in AUROC, and 0.76% in AUPRC,\nalong with a notable 3.04% decrease in the Brier score, demonstrating marked\nimprovements in accuracy, reliability, and prediction calibration over the\nbaseline XLM model. The source code will be made publicly available.", "paper_summary_zh": "<paragraph>\u5c0f\u5152\u6025\u8a3a\u90e8\uff08PED\uff09\u4eba\u6eff\u70ba\u60a3\u662f\u4e00\u500b\u91cd\u5927\u7684\u5168\u7403\u6027\u6311\u6230\uff0c\u4fc3\u4f7f\u6211\u5011\u9700\u8981\u627e\u51fa\u6709\u6548\u7387\u7684\u89e3\u6c7a\u65b9\u6848\u3002\u672c\u6587\u4ecb\u7d39 BioBridge \u67b6\u69cb\uff0c\u9019\u662f\u4e00\u7a2e\u5275\u65b0\u7684\u65b9\u6cd5\uff0c\u5c07\u81ea\u7136\u8a9e\u8a00\u8655\u7406\uff08NLP\uff09\u61c9\u7528\u65bc\u4ee5\u81ea\u7531\u6587\u5b57\u5f62\u5f0f\u64b0\u5beb\u7684\u96fb\u5b50\u75c5\u6b77\uff08EMR\uff09\uff0c\u4ee5\u589e\u5f37\u5728 PED \u4e2d\u7684\u6c7a\u7b56\u5236\u5b9a\u3002\u5728\u975e\u82f1\u8a9e\u7cfb\u570b\u5bb6/\u5730\u5340\uff08\u4f8b\u5982\u5357\u97d3\uff09\uff0cEMR \u8cc7\u6599\u901a\u5e38\u4ee5\u4ee3\u78bc\u8f49\u63db\uff08CS\uff09\u683c\u5f0f\u64b0\u5beb\uff0c\u5c07\u6bcd\u8a9e\u8207\u82f1\u8a9e\u6df7\u5408\uff0c\u800c\u5927\u591a\u6578\u4ee3\u78bc\u8f49\u63db\u7684\u82f1\u8a9e\u55ae\u5b57\u5177\u6709\u81e8\u5e8a\u610f\u7fa9\u3002BioBridge \u67b6\u69cb\u5305\u542b\u5169\u500b\u6838\u5fc3\u6a21\u7d44\uff1a\u300c\u8a9e\u5883\u4e2d\u7684\u6a4b\u63a5\u65b9\u5f0f\u300d\u548c\u300c\u7d71\u4e00\u751f\u7269\u5d4c\u5165\u300d\u3002\u300c\u8a9e\u5883\u4e2d\u7684\u6a4b\u63a5\u65b9\u5f0f\u300d\u6a21\u7d44\u6539\u5584\u4e86\u96d9\u8a9e\u548c\u4ee3\u78bc\u8f49\u63db EMR \u7684\u8a9e\u5883\u7406\u89e3\u3002\u5728\u300c\u7d71\u4e00\u751f\u7269\u5d4c\u5165\u300d\u6a21\u7d44\u4e2d\uff0c\u5c07\u5728\u91ab\u7642\u9818\u57df\u8a13\u7df4\u7684\u6a21\u578b\u77e5\u8b58\u6ce8\u5165\u5230\u57fa\u65bc\u7de8\u78bc\u5668\u7684\u6a21\u578b\u4e2d\uff0c\u4ee5\u5f4c\u5408\u91ab\u7642\u548c\u4e00\u822c\u9818\u57df\u4e4b\u9593\u7684\u5dee\u8ddd\u3002\u5be6\u9a57\u7d50\u679c\u8b49\u660e\uff0c\u6240\u63d0\u51fa\u7684 BioBridge \u5728\u591a\u9805\u6307\u6a19\uff08\u5305\u62ec F1 \u5206\u6578\u3001\u53d7\u8a66\u8005\u64cd\u4f5c\u7279\u5fb5\u66f2\u7dda\u4e0b\u9762\u7a4d\uff08AUROC\uff09\u3001\u7cbe\u78ba\u5ea6\u53ec\u56de\u7387\u66f2\u7dda\u4e0b\u9762\u7a4d\uff08AUPRC\uff09\u548c\u5e03\u8cf4\u723e\u5206\u6578\uff09\u4e0a\u986f\u8457\u512a\u65bc\u50b3\u7d71\u6a5f\u5668\u5b78\u7fd2\u548c\u9810\u5148\u8a13\u7df4\u7684\u57fa\u65bc\u7de8\u78bc\u5668\u7684\u6a21\u578b\u3002\u5177\u9ad4\u4f86\u8aaa\uff0cBioBridge-XLM \u5728 F1 \u5206\u6578\u4e0a\u63d0\u5347\u4e86 0.85%\uff0c\u5728 AUROC \u4e0a\u63d0\u5347\u4e86 0.75%\uff0c\u5728 AUPRC \u4e0a\u63d0\u5347\u4e86 0.76%\uff0c\u540c\u6642\u5e03\u8cf4\u723e\u5206\u6578\u986f\u8457\u4e0b\u964d\u4e86 3.04%\uff0c\u8b49\u660e\u5728\u6e96\u78ba\u5ea6\u3001\u53ef\u9760\u6027\u548c\u9810\u6e2c\u6821\u6e96\u65b9\u9762\uff0c\u8207\u57fa\u6e96 XLM \u6a21\u578b\u76f8\u6bd4\u90fd\u6709\u986f\u8457\u7684\u6539\u5584\u3002\u539f\u59cb\u78bc\u5c07\u516c\u958b\u63d0\u4f9b\u3002</paragraph>", "author": "Jangyeong Jeon et.al.", "authors": "Jangyeong Jeon, Sangyeon Cho, Dongjoon Lee, Changhee Lee, Junyeong Kim", "id": "2412.11671v1", "paper_url": "http://arxiv.org/abs/2412.11671v1", "repo": "https://github.com/jjy961228/biobridge"}}